Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection
Audrey V. Parent, Gaetano Faleo, Jessica Chavez, et al.
Cell Reports (2021) Vol. 36, Iss. 7, pp. 109538-109538
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes
Nathaniel J. Hogrebe, Matthew Ishahak, Jeffrey R. Millman
Cell stem cell (2023) Vol. 30, Iss. 5, pp. 530-548
Open Access | Times Cited: 89
Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance
Dario Gerace, Quan Zhou, Jennifer Hyoje-Ryu Kenty, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 1, pp. 100879-100879
Open Access | Times Cited: 51
Single-nucleus multi-omics of human stem cell-derived islets identifies deficiencies in lineage specification
Punn Augsornworawat, Nathaniel J. Hogrebe, Matthew Ishahak, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 6, pp. 904-916
Open Access | Times Cited: 38
Stomach-derived human insulin-secreting organoids restore glucose homeostasis
Xiaofeng Huang, Wei Yong Gu, Jiaoyue Zhang, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 5, pp. 778-786
Closed Access | Times Cited: 30
Current trends of clinical trials involving CRISPR/Cas systems
Song‐Yang Zhang, Yidi Wang, Dezhi Mao, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 25
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead
Alessandro Grattoni, Gregory S. Korbutt, Alice A. Tomei, et al.
Nature Reviews Endocrinology (2024) Vol. 21, Iss. 1, pp. 14-30
Closed Access | Times Cited: 15
Identification of unique cell type responses in pancreatic islets to stress
Marlie M. Maestas, Matthew Ishahak, Punn Augsornworawat, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Genetically engineered hypoimmunogenic cell therapy
Akitsu Hotta, Sonja Schrepfer, András Nagy
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 11, pp. 960-979
Closed Access | Times Cited: 9
Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets
Elad Sintov, Igor Nikolskiy, Víctor Barrera, et al.
Stem Cell Reports (2022) Vol. 17, Iss. 9, pp. 1976-1990
Open Access | Times Cited: 32
Emerging diabetes therapies: Bringing back the β-cells
Giorgio Basile, Mirza Muhammad Fahd Qadir, Franck Mauvais‐Jarvis, et al.
Molecular Metabolism (2022) Vol. 60, pp. 101477-101477
Open Access | Times Cited: 30
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
Nishith R. Reddy, Hasna Maachi, Yini Xiao, et al.
Science (2024) Vol. 386, Iss. 6726
Closed Access | Times Cited: 8
Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation
Beatrice Xuan Ho, Adrian Kee Keong Teo, Natasha Hui Jin Ng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Type 1 diabetes and engineering enhanced islet transplantation
Abiramy Jeyagaran, Chuan‐en Lu, Aline Zbinden, et al.
Advanced Drug Delivery Reviews (2022) Vol. 189, pp. 114481-114481
Open Access | Times Cited: 28
The beta cell-immune cell interface in type 1 diabetes (T1D)
Eddie A. James, Alok V. Joglekar, Amelia K. Linnemann, et al.
Molecular Metabolism (2023) Vol. 78, pp. 101809-101809
Open Access | Times Cited: 15
Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
Dmitry S. Karpov, Anastasiia O. Sosnovtseva, S. V. Pylina, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17320-17320
Open Access | Times Cited: 13
Encapsulation and immune protection for type 1 diabetes cell therapy
Sophia Kioulaphides, Andrés J. Garcı́a
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115205-115205
Closed Access | Times Cited: 5
Mechanism of Action of Oral Salmonella-Based Vaccine to Prevent and Reverse Type 1 Diabetes in NOD Mice
Jacob Cobb, Jeffrey Rawson, Nelson Gonzalez, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 276-276
Open Access | Times Cited: 5
Considerations and challenges of islet transplantation and future therapies on the horizon
Sophie Walker, Mahesh Appari, Shareen Forbes
AJP Endocrinology and Metabolism (2021) Vol. 322, Iss. 2, pp. E109-E117
Open Access | Times Cited: 29
Immune Editing: Overcoming Immune Barriers in Stem Cell Transplantation
Torsten Meißner, Henrike S. Schulze, Stanley M. Dale
Current Stem Cell Reports (2022) Vol. 8, Iss. 4, pp. 206-218
Open Access | Times Cited: 19
A Cure for Type 1 Diabetes: Are We There Yet?
Christian P. Schaaf, Lori Sussel
Diabetes Technology & Therapeutics (2025)
Closed Access
The future of islet transplantation beyond the BLA approval: challenges and opportunities
Yong Wang, James J. McGarrigle, Judith W. Cook, et al.
Frontiers in Transplantation (2025) Vol. 4
Open Access
A perfect islet: reviewing recent protocol developments and proposing strategies for stem cell derived functional pancreatic islets
Sujitha Sali, Leen Azzam, Taraf Jaro, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Progress and challenges in developing allogeneic cell therapies
T. Deuse, Sonja Schrepfer
Cell stem cell (2025) Vol. 32, Iss. 4, pp. 513-528
Open Access
Cell Therapy for T1D Beyond BLA: Gearing Up Toward Clinical Practice
Yong Wang, Yingying Chen, James J. McGarrigle, et al.
Diabetes Therapy (2025)
Open Access
Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockout
Juryun Kim, Yoojun Nam, Doyeong Jeon, et al.
Experimental & Molecular Medicine (2025)
Open Access
Page 1 - Next Page

Scroll to top